Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive-stage Small Cell Lung Cancer (ES-SCLC)”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Early research (Phase 1)Looking for participantsNCT07413042
What this trial is testing

A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

Who this might be right for
SCLC, Extensive Stage
Peking University Cancer Hospital & Institute 24
Large-scale testing (Phase 3)Study completedNCT04878016
What this trial is testing

Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Lee's Pharmaceutical Limited 498
Post-approval studies (Phase 4)Looking for participantsNCT05874401
What this trial is testing

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Pharmacosmos A/S 302
Large-scale testing (Phase 3)Study completedNCT03066778
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Who this might be right for
Small Cell Lung Cancer (SCLC)
Merck Sharp & Dohme LLC 453
Testing effectiveness (Phase 2)Looking for participantsNCT06838208
What this trial is testing

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital 56
Testing effectiveness (Phase 2)Looking for participantsNCT07339059
What this trial is testing

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer ( SCLC )Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Bindu R Potugari 35
Testing effectiveness (Phase 2)UnknownNCT04985201
What this trial is testing

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06554535
What this trial is testing

Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-Stage Small Cell Lung CancerTreatment-naïve for Systemic Therapy Targeting Extensive-Stage Small Cell Lung CancerECOG Performance Status Score of 0 or 1+1 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT04221529
What this trial is testing

Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Who this might be right for
SCLC, Extensive Stage
AIO-Studien-gGmbH 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07349225
What this trial is testing

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
ES-SCLC
The Second Affiliated Hospital of Dalian Medical University 46
Testing effectiveness (Phase 2)Study completedNCT00388960
What this trial is testing

Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Celgene 99
Testing effectiveness (Phase 2)WithdrawnNCT06052423
What this trial is testing

ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Hansoh BioMedical R&D Company
Testing effectiveness (Phase 2)UnknownNCT05896059
What this trial is testing

Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Zhejiang Cancer Hospital 21
Early research (Phase 1)Temporarily pausedNCT05403723
What this trial is testing

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
University of Maryland, Baltimore 50
Not applicableUnknownNCT04663438
What this trial is testing

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Peking Union Medical College Hospital 300
Not applicableUnknownNCT04985851
What this trial is testing

To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Shanghai Chest Hospital 90
Testing effectiveness (Phase 2)Study completedNCT04924101
What this trial is testing

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Who this might be right for
Small Cell Lung Cancer
Merck Sharp & Dohme LLC 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728230
What this trial is testing

Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699838
What this trial is testing

Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Muhammad Furqan 30
Next Page
43